Literature DB >> 18725623

Suppression of E-protein activity interferes with the development of BCR-ABL-mediated myeloproliferative disease.

Jinkyung Ko1, Nihal Patel, Tomokatsu Ikawa, Hiroshi Kawamoto, Oliver Frank, Richard R Rivera, Richard A Van Etten, Cornelis Murre.   

Abstract

E-proteins are a class of helix-loop-helix (HLH) proteins, which play multiple roles throughout lymphoid development. The DNA binding activities of the E-proteins are regulated by a distinct class of antagonistic HLH proteins, named Id1-4. Here we demonstrate that Id2 deficient mice in a C57BL/6 genetic background exhibit increased cellularity in the granulocyte/myeloid progenitor compartment and show significantly higher numbers of maturing neutrophils. Within 6 months of age, Id2 deficient mice succumbed from overwhelming granulocytosis. The disease closely mimicked the distinctive features of human chronic myeloid leukemia: leukocytosis with maturing neutrophils, splenomegaly, hepatomegaly, and myeloid infiltration into peripheral tissues, including spleen, liver, and lungs. Strikingly, forced Id2 expression in murine bone marrow cells substantially delayed the onset of myeloproliferative disease (MPD). Collectively, these studies show that suppression of E-protein activity interferes with the development of BCR-ABL-mediated MPD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725623      PMCID: PMC2529058          DOI: 10.1073/pnas.0805073105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  The biology of chronic myeloid leukemia.

Authors:  S Faderl; M Talpaz; Z Estrov; S O'Brien; R Kurzrock; H M Kantarjian
Journal:  N Engl J Med       Date:  1999-07-15       Impact factor: 91.245

2.  Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2.

Authors:  Y Yokota; A Mansouri; S Mori; S Sugawara; S Adachi; S Nishikawa; P Gruss
Journal:  Nature       Date:  1999-02-25       Impact factor: 49.962

Review 3.  Focus on myeloproliferative diseases and myelodysplastic syndromes.

Authors:  Richard A Van Etten; Kevin M Shannon
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

4.  Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2.

Authors:  Miranda Buitenhuis; Hanneke W M van Deutekom; Liesbeth P Verhagen; Anders Castor; Sten Eirik W Jacobsen; Jan-Willem J Lammers; Leo Koenderman; Paul J Coffer
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

Review 5.  Helix-loop-helix proteins and lymphocyte development.

Authors:  Cornelis Murre
Journal:  Nat Immunol       Date:  2005-11       Impact factor: 25.606

6.  High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice.

Authors:  W Yan; A Z Young; V C Soares; R Kelley; R Benezra; Y Zhuang
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

7.  Overexpression of the Helix-Loop-Helix protein Id2 blocks T cell development at multiple stages.

Authors:  M A Morrow; E W Mayer; C A Perez; M Adlam; G Siu
Journal:  Mol Immunol       Date:  1999-06       Impact factor: 4.407

8.  Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.

Authors:  W S Pear; J P Miller; L Xu; J C Pui; B Soffer; R C Quackenbush; A M Pendergast; R Bronson; J C Aster; M L Scott; D Baltimore
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

9.  E proteins and Notch signaling cooperate to promote T cell lineage specification and commitment.

Authors:  Tomokatsu Ikawa; Hiroshi Kawamoto; Ananda W Goldrath; Cornelis Murre
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

10.  The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.

Authors:  S Li; R L Ilaria; R P Million; G Q Daley; R A Van Etten
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

View more
  7 in total

1.  A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.

Authors:  Xiaoxue Qiu; Guijie Guo; Ke Chen; Masaki Kashiwada; Brian J Druker; Paul B Rothman; Ji-Long Chen
Journal:  Neoplasia       Date:  2012-06       Impact factor: 5.715

2.  ID2 and HIF-1α collaborate to protect quiescent hematopoietic stem cells from activation, differentiation, and exhaustion.

Authors:  Brad L Jakubison; Tanmoy Sarkar; Kristbjorn O Gudmundsson; Shweta Singh; Lei Sun; Holly M Morris; Kimberly D Klarmann; Jonathan R Keller
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

3.  Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia.

Authors:  X Zhang; W Ma; J Cui; H Yao; H Zhou; Y Ge; L Xiao; X Hu; B-H Liu; J Yang; Y-Y Li; S Chen; C J Eaves; D Wu; Y Zhao
Journal:  Oncogene       Date:  2014-08-04       Impact factor: 9.867

4.  The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis.

Authors:  Masaki Miyazaki; Kazuko Miyazaki; Shuwen Chen; Vivek Chandra; Keisuke Wagatsuma; Yasutoshi Agata; Hans-Reimer Rodewald; Rintaro Saito; Aaron N Chang; Nissi Varki; Hiroshi Kawamoto; Cornelis Murre
Journal:  Genes Dev       Date:  2015-02-15       Impact factor: 11.361

Review 5.  Inhibitor of DNA binding in heart development and cardiovascular diseases.

Authors:  Wenyu Hu; Yanguo Xin; Jian Hu; Yingxian Sun; Yinan Zhao
Journal:  Cell Commun Signal       Date:  2019-05-24       Impact factor: 5.712

6.  Inhibitor of Differentiation-2 Protein Ameliorates DSS-Induced Ulcerative Colitis by Inhibiting NF-κB Activation in Neutrophils.

Authors:  Jie Ren; Dong Yan; Yichun Wang; Jiaojiao Zhang; Min Li; Wancheng Xiong; Xueqian Jing; Puze Li; Weidong Zhao; Xiwen Xiong; Minna Wu; Genshen Zhong
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

Review 7.  Inhibitor of DNA binding proteins revealed as orchestrators of steady state, stress and malignant hematopoiesis.

Authors:  Shweta Singh; Tanmoy Sarkar; Brad Jakubison; Stephen Gadomski; Andrew Spradlin; Kristbjorn O Gudmundsson; Jonathan R Keller
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.